SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-060905
Filing Date
2018-10-09
Accepted
2018-10-09 06:10:44
Documents
3
Period of Report
2018-10-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36447_18k.htm 8-K 19744
2 EX-99.1 a18-36447_1ex99d1.htm EX-99.1 27540
3 GRAPHIC g364471mmi001.jpg GRAPHIC 3503
  Complete submission text file 0001104659-18-060905.txt   53569
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 181112023
SIC: 2834 Pharmaceutical Preparations